Related references
Note: Only part of the references are listed.Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis
Qiyan Zheng et al.
FRONTIERS IN PHARMACOLOGY (2021)
Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial
Masaomi Nangaku et al.
AMERICAN JOURNAL OF NEPHROLOGY (2021)
Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The multifaceted role of iron in renal health and disease
Rachel P. L. van Swelm et al.
NATURE REVIEWS NEPHROLOGY (2020)
Efficacy and Safety of Daprodustat Compared with Darbepoetin Alfa in Japanese Hemodialysis Patients with Anemia A Randomized, Double-Blind, Phase 3 Trial
Tadao Akizawa et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis
Qiyan Zheng et al.
PHARMACOLOGICAL RESEARCH (2020)
Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients
Takahiro Kuragano et al.
PLOS ONE (2020)
Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients
Bin Wang et al.
RENAL FAILURE (2020)
Balanced crystalloids versus normal saline for fluid resuscitation in critically ill patients: A systematic review and meta-analysis with trial sequential analysis
Chao Liu et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2019)
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
Louis Holdstock et al.
CLINICAL KIDNEY JOURNAL (2019)
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis
Amy M. Meadowcroft et al.
CLINICAL KIDNEY JOURNAL (2019)
Iron Deficiency Anemia in Chronic Kidney Disease
Anat Gaiter-Gvili et al.
ACTA HAEMATOLOGICA (2019)
VEGF - A Stimulus for Neuronal Development and Regeneration in the CNS and PNS
Verena Theis et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer
Hiroshi Sawayama et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Joshua M. Kaplan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Hypoxia-inducible factor stabilizers for treating anemia of chronic kidney disease
Sho Hasegawa et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2018)
Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis
Dengpiao Xie et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2018)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
Nupur Gupta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
Louis Holdstock et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
New Treatment Approaches for the Anemia of CKD
Mario Bonomini et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Robert Provenzano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study
Yuzo Watanabe et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2016)
VEGF and Intraocular Neovascularization: From Discovery to Therapy
Napoleone Ferrara
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2016)
Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials
Chao Liu et al.
CRITICAL CARE (2016)
Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2015)
Anaemia in kidney disease: harnessing hypoxia responses for therapy
Mark J. Koury et al.
NATURE REVIEWS NEPHROLOGY (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
ESA and iron therapy in chronic kidney disease: a balance between patient safety and hemoglobin target
Szu-Chun Hung et al.
KIDNEY INTERNATIONAL (2014)
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Ioannis Koulouridis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Mechanisms of Hypoxia Responses in Renal Tissue
Volker H. Haase
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
Tineke W. H. Meijer et al.
CLINICAL CANCER RESEARCH (2012)
Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis
Simon Beuck et al.
DRUG TESTING AND ANALYSIS (2012)
Mechanisms of Anemia in CKD
Jodie L. Babitt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s)
Tilman B. Drueeke et al.
KIDNEY INTERNATIONAL (2012)
Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways
Manfred Nairz et al.
IMMUNITY (2011)
Hepcidin: clinical utility as a diagnostic tool and therapeutic target
Daniel W. Coyne
KIDNEY INTERNATIONAL (2011)
Intravenous Iron Versus Erythropoiesis-Stimulating Agents: Friends or Foes in Treating Chronic Kidney Disease Anemia?
Kamyar Kalantar-Zadeh et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2009)
Association of Serum Total Iron-Binding Capacity and Its Changes Over Time with Nutritional and Clinical Outcomes in Hemodialysis Patients
Rachelle Bross et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients
Elisio Costa et al.
AMERICAN JOURNAL OF NEPHROLOGY (2008)
Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
Jesper Brok et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Direct regulation of TWIST by HIF-1α promotes metastasis
Muh-Hwa Yang et al.
NATURE CELL BIOLOGY (2008)
Chronic kidney disease and its complications
Robert Thomas et al.
PRIMARY CARE (2008)
Stimulation of HIF-1α, HIF-2α, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells
TM Asikainen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
The role of vascular endothelial growth factor \in ocular health and disease
AP Adamis et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease
JA Eustace et al.
KIDNEY INTERNATIONAL (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
T Ganz
BLOOD (2003)
Share Paper
